<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149691">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01921088</url>
  </required_header>
  <id_info>
    <org_study_id>NF1_137023_A</org_study_id>
    <nct_id>NCT01921088</nct_id>
  </id_info>
  <brief_title>Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Regulation of Psychophysiological Functions</brief_title>
  <official_title>Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Regulation of Psychophysiological Functions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marion Tegethoff</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Basel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the potential efficacy of real-time functional
      magnetic resonance imaging neurofeedback (RT-fMRI-NF) in regulating brain activity and
      psychophysiological functions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall goal of the outlined study is to establish a real-time functional magnetic
      resonance imaging neurofeedback (RT-fMRI-NF) protocol aiming at modulating brain activity
      and psychophysiological functions. About two weeks after the initial training session it
      will be estimated how stable training effects have been. The two weeks in between, subjects
      will receive ambulatory training of the strategies via a smartphone-based application.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>study day 1; study day 2 (2 weeks later); anticipated: follow-up (up to 1 year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed via oscillometry, expressed in mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood oxygenation level dependent signal of the target brain region of interest</measure>
    <time_frame>study day 1; study day 2 (2 weeks later); anticipated: follow-up (up to 1 year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>blood oxygenation level dependent (BOLD) signal assessed via functional magnetic resonance imaging, expressed in relative BOLD signal intensity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feedback on adverse events during the scanner and ambulatory training</measure>
    <time_frame>study day 1; study day 2 (2 weeks later); anticipated: follow-up (up to 1 year)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>number of subjects reporting an adverse event</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Psychobiological stress reactivity</measure>
    <time_frame>study day 1; study day 2 (2 weeks later); anticipated: follow-up (up to 1 year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed via heart rate, cortisol</description>
  </other_outcome>
  <other_outcome>
    <measure>Psychological stress reactivity</measure>
    <time_frame>study day 1; study day 2 (2 weeks later); anticipated: follow-up (up to 1 year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>assessed via Multidimensional Mood State Questionnaire; Self-Assessment Manikin; Perceived Stress Scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional connectivity</measure>
    <time_frame>study day 1; study day 2 (2 weeks later); anticipated: follow-up (up to 1 year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>connectivity of brain activity determined by fmri signal</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Stress</condition>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Contingent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Contingent RT-fMRI-NF of brain activity in the target region of interest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-contingent</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham RT-fMRI-NF of brain activity of previously recorded subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>real-time functional magnetic resonance imaging neurofeedback (RT-fMRI-NF)</intervention_name>
    <description>Subjects are provided with RT-fMRI-NF.</description>
    <arm_group_label>Contingent</arm_group_label>
    <arm_group_label>Non-contingent</arm_group_label>
    <other_name>There are no specific branded names etc. associated with the intervention.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Ambulatory Training</intervention_name>
    <description>Subjects are provided with an ambulatory training.</description>
    <arm_group_label>Contingent</arm_group_label>
    <arm_group_label>Non-contingent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sufficient spoken and written knowledge of English

          -  Right-handedness

          -  Access to smartphone

          -  Availability to participate in the study

        Exclusion Criteria:

          -  Color blindness

          -  Presence of cardiovascular disease

          -  Medication intake affecting cardiovascular function

          -  Medical MRI contraindication
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marion Tegethoff, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Basel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jong-Hwan Lee, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gunther Meinlschmidt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Basel;Ruhr-University Bochum</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marion Tegethoff, Ph.D.</last_name>
    <phone>++41 61 267 02 61</phone>
    <email>marion.tegethoff@unibas.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Korea University</name>
      <address>
        <city>Seoul</city>
        <zip>136-713</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jong-Hwan Lee, Ph.D.</last_name>
      <phone>+82-10-2733-3659</phone>
      <email>jhlee.jonghwanlee@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jong-Hwan Lee, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 8, 2013</lastchanged_date>
  <firstreceived_date>August 2, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Marion Tegethoff</investigator_full_name>
    <investigator_title>PD Dr.</investigator_title>
  </responsible_party>
  <keyword>fMRI</keyword>
  <keyword>Neurofeedback</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Psychophysiology</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
